NEW YORK, May 14 /PRNewswire-FirstCall/ -- U.S. Bancorp Piper Jaffray
(Piper Jaffray) is pleased to announce that Edward (Ted) Tenthoff, 31, has
joined the firm as a senior research analyst covering the genomics sector with
a focus on tools, early drug discovery and diagnostic companies. Tenthoff will
join Piper Jaffray's biotechnology research team in New York, which consists
of Tim Coan covering specialty pharmaceuticals, Mark Schoenebaum covering
biopharmaceuticals and Thomas Wei covering therapeutics.
Tenthoff joins the firm from Think Equity Partners in New York, where he
was a senior research analyst covering biotechnology/genomics companies. Prior
to that, he was a senior research analyst at Robertson Stephens in New York,
where he also covered the biotechnology industry. In addition, Tenthoff
covered medical technology as a research analyst at First Albany Corporation,
Rodman and Renshaw, Inc., and Lehman Brothers in New York.
"We are thrilled to have Ted join our research team," said Robert
Peterson, head of Research at U.S. Bancorp Piper Jaffray. "He truly rounds out
our biotechnology coverage and will play an integral role in our attempt to
differentiate our biotechnology efforts through independent, impactful and
Tenthoff holds a bachelor's degree in international relations from the
University of Pennsylvania in Philadelphia, Penn. In addition, he has
completed coursework in molecular biology and genetics at Columbia University
in New York.
"Joining Piper Jaffray's health care team is a tremendous opportunity,"
said Tenthoff. "I am looking forward to contributing my expertise and
background in the tools and genomics sector to an already established
U.S. Bancorp Piper Jaffray, a subsidiary of Minneapolis-based U.S. Bancorp
(NYSE: USB), is a focused securities firm comprised of four lines of business:
Equity Capital Markets, Fixed Income Capital Markets, Private Advisory
Services and Research. The firm provides a full range of investment products
and services to individuals, institutions and businesses and has over 124
offices in 25 states across the country. For more information on U.S. Bancorp
Piper Jaffray, visit www.piperjaffray.com .
This press release contains forward-looking statements. Statements that
are not historical or current facts, including statements about beliefs and
expectations, are forward-looking statements. These forward-looking
statements are subject to risks and uncertainties relating to the proposed
spin-off of the U.S. Bancorp Piper Jaffray business, including the impact of
the proposed spin-off on U.S. Bancorp's and the new company's results of
operations, the financial accounting consequences of the proposed transaction,
the impact of the spin-off on U.S. Bancorp's stock price and on its and the
new company's relationships with their respective customers and employees, the
tax consequences of the transaction to U.S. Bancorp, the new company and their
respective stockholders, changes in business climate or market conditions or
other factors which could make the proposed spin-off unadvisable. These
forward-looking statements involve other inherent risks and uncertainties, and
other important factors could cause actual results to differ materially from
those anticipated, including those contained in U.S. Bancorp's Form 10-K and
other reports on file with the U.S. Securities and Exchange Commission.
Forward-looking statements speak only as of the date they are made, and U.S.
Bancorp undertakes no obligation to update them in light of new information or
U.S. Bancorp Piper Jaffray, 800 Nicollet Mall, Suite 800, Minneapolis,
Additional information is available upon request.
SOURCE U.S. Bancorp Piper Jaffray